Top compounds associated with response to ONECUT2


Feature Type Standardized
Nominal ANOVA
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.2 1e-09
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.2 8e-09
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.29 1e-08
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA HG-6-64-1 GDSC1000 pan-cancer AAC -0.17 3e-06
mRNA AUY922 GDSC1000 pan-cancer AAC -0.17 3e-06
Download CSV